Lexaria Bioscience Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/12/2024 | Q3 2024 | -$0.13 | $84,000 | |||
| 04/09/2024 | Q2 2024 | -$0.06 | $145,000 | |||
| 01/12/2024 | Q1 2024 | -$0.13 | $151,278 | |||
| 11/20/2023 | Q4 2023 | -$0.19 | $-3,433 | |||
| 07/14/2023 | Q3 2023 | -$0.37 | $93,150 | |||
| 04/14/2023 | Q2 2023 | -$0.22 | $35,015 | |||
| 01/18/2023 | Q1 2023 | -$0.30 | $101,476 | |||
| 11/25/2022 | Q4 2022 | -$0.25 | $111,150 | |||
| 07/14/2022 | Q3 2022 | -$0.40 | $99,717 | |||
| 04/11/2022 | Q2 2022 | -$0.24 | $30,650 | |||
| 01/14/2022 | Q1 2022 | -$0.35 | $13,880 | |||
| 11/26/2021 | Q4 2021 | -$0.23 | $31,021 | |||
| 07/15/2021 | Q3 2021 | -$0.50 | $204,055 | |||
| 04/14/2021 | Q2 2021 | $0.09 | $192,006 | |||
| 01/14/2021 | Q1 2021 | -$0.23 | $295,656 | |||
| 10/14/2020 | Q4 2020 | -$0.14 | $133,739 | |||
| 06/30/2020 | Q3 2020 | -$0.49 | $81,423 | |||
| 04/02/2020 | Q2 2020 | -$0.36 | $107,299 | |||
| 01/08/2020 | Q1 2020 | -$0.34 | $62,082 | |||
| 11/14/2019 | Q4 2019 | -$0.41 | $125,121 |
Lexaria Bioscience Corp. Earnings: Frequently Asked Questions
-
When is Lexaria Bioscience Corp.'s earnings date?
Lexaria Bioscience Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 30th, 2023 based off last year's report dates.
-
How can I listen to Lexaria Bioscience Corp.'s earnings conference call?
The conference call for Lexaria Bioscience Corp.'s latest earnings report can be listened to online.
-
How can I read Lexaria Bioscience Corp.'s conference call transcript?
The conference call transcript for Lexaria Bioscience Corp.'s latest earnings report can be read online.
-
How much revenue does Lexaria Bioscience Corp. generate each year?
Lexaria Bioscience Corp. (:LEXXW) has a recorded annual revenue of $226,208.
-
How much profit does Lexaria Bioscience Corp. generate each year?
Lexaria Bioscience Corp. (:LEXXW) has a recorded net income of $226,208. Lexaria Bioscience Corp. has generated $-1.01 earnings per share over the last four quarters.
-
What is Lexaria Bioscience Corp.'s price-to-earnings ratio?
Lexaria Bioscience Corp. (:LEXXW) has a price-to-earnings ratio of -6.37 and price/earnings-to-growth ratio is -0.2.
